Qvar Redihaler Aerosol, Metered
NDC Package 50090-5032-0
Package Information
Qvar Redihaler (beclomethasone dipropionate hfa) aerosols is qVAR REDIHALER is indicated in the maintenance treatment of asthma as prophylactic therapy in adults and pediatric patients 4 years of age and older.Limitations of Use:QVAR REDIHALER is not indicated for the relief of acute bronchospasm. . This formulation utilizes a aerosol, metered delivery system. Marketed by A-s Medication Solutions, this product is identified by NDC 50090-5032 and is authorized under FDA application NDA207921.
Identification & Billing
- RxCUI: 1998771 - beclomethasone dipropionate 80 MCG/ACTUAT Breath-Actuated Metered Dose Inhaler, 120 ACTUAT
- RxCUI: 1998771 - Breath-Actuated 120 ACTUAT beclomethasone dipropionate 0.08 MG/ACTUAT Metered Dose Inhaler
- RxCUI: 1998772 - QVAR Redihaler 80 MCG/ACTUAT Breath-Actuated Metered Dose Inhaler, 120 ACTUAT
- RxCUI: 1998772 - Breath-Actuated 120 ACTUAT beclomethasone dipropionate 0.08 MG/ACTUAT Metered Dose Inhaler [Qvar]
- RxCUI: 1998772 - Breath-Actuated 120 ACTUAT Qvar 0.08 MG/ACTUAT Metered Dose Inhaler
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 50090 - A-s Medication Solutions
- 50090-5032 - Qvar Redihaler
- 50090-5032-0 - 1 INHALER in 1 CARTON / 1 AEROSOL, METERED in 1 INHALER
- 50090-5032 - Qvar Redihaler
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 50090-5032-0 identifies a specific commercial package of 1 inhaler in 1 carton / 1 aerosol, metered in 1 inhaler of Qvar Redihaler, a human prescription drug labeled by A-s Medication Solutions. This aerosol, metered is formulated for respiratory (inhalation) use and contains beclomethasone dipropionate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by A-s Medication Solutions on February 15, 2018. The current certification is valid through December 31, 2026.
How is this A-s Medication Solutions product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 50090503200. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.